Clinical Trial Update: Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT [NA]

View source ↗

Summary

This entry reports an ongoing clinical trial evaluating immune response in oligorecurrent and oligoprogressive prostate cancer patients treated with SBRT, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Oligorecurrent and Oligoprogressive Prostate Cancer Patients | NA | Status: ACTIVE_NOT_RECRUITING